Anderson P W, Pichichero M E, Stein E C, Porcelli S, Betts R F, Connuck D M, Korones D, Insel R A, Zahradnik J M, Eby R
Department of Pediatrics, University of Rochester, NY 14642.
J Immunol. 1989 Apr 1;142(7):2464-8.
Vaccines consisting of oligosaccharide (OS) derived from Haemophilus influenzae type b capsular polysaccharide and conjugated to carrier proteins had been shown capable of eliciting memory-type capsular polysaccharide of H. influenza type b antibody responses in human infants, but the structural variables governing immunogenicity were not defined. Here a series of conjugates were made with the diphtheria protein CRM197 and with uniterminally coupled OS haptens that varied in chain length, exposed terminal residue, or multiplicity of loading as defined by ribose/protein ratio. Adults were given a single injection, 1-yr-old infants were given a two-injection sequence, and capsular polysaccharide of H. influenzae type b antibody responses were assessed by radioantigen binding. Vaccines C-4r, C-6r, and C-12r, in which ribitol-ended OS of mean length 4, 6, or 12 repeat units were coupled at low hapten loading, were about equally immunogenic (geometric means 2 to 5 micrograms/ml in infants, 5 to 9 micrograms/ml in adults). Vaccine C7p was made with a higher loading of OS having mean length 7 repeat units and having mainly phosphate monoester at the exposed termini Vaccine C-7R was made from a portion of C-7p by enzymatic removal of most of the terminal phosphates. Compared to the C-4r, C-6r, and C-12r series, vaccines C-7p and C-7R induced geometric means about 10-fold higher in adults and 20-fold higher in infants. Thus OS chain length (in the range studied) and exposed terminus are less critical variables in this system than the extent of hapten loading.
由b型流感嗜血杆菌荚膜多糖衍生并与载体蛋白偶联的寡糖(OS)疫苗已被证明能够在人类婴儿中引发记忆型b型流感嗜血杆菌荚膜多糖抗体反应,但尚未确定影响免疫原性的结构变量。在此,制备了一系列与白喉蛋白CRM197以及与单末端偶联的OS半抗原的缀合物,这些半抗原在链长、暴露的末端残基或由核糖/蛋白质比率定义的负载多重性方面有所不同。给成年人单次注射,给1岁婴儿进行两次注射序列,并通过放射性抗原结合评估b型流感嗜血杆菌荚膜多糖抗体反应。疫苗C-4r、C-6r和C-12r,其中平均长度为4、6或12个重复单元的核糖醇末端OS以低半抗原负载量偶联,免疫原性大致相同(婴儿中的几何平均值为2至5微克/毫升,成年人中的几何平均值为5至9微克/毫升)。疫苗C7p是用平均长度为7个重复单元且在暴露末端主要具有磷酸单酯的较高负载量的OS制备的。疫苗C-7R是通过酶促去除大部分末端磷酸盐从C-7p的一部分制备的。与C-4r、C-6r和C-12r系列相比,疫苗C-7p和C-7R在成年人中诱导的几何平均值高约10倍,在婴儿中高约20倍。因此,在该系统中,OS链长(在所研究的范围内)和暴露末端比半抗原负载程度是不太关键的变量。